These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 28169606)
1. The real-life number of neonatal doses of Bacille Calmette-Guérin vaccine in a 20-dose vial. Schaltz-Buchholzer F; Frankel HN; Benn CS Glob Health Action; 2017; 10(1):1-4. PubMed ID: 28169606 [TBL] [Abstract][Full Text] [Related]
3. Early Vaccination With Bacille Calmette-Guérin-Denmark or BCG-Japan Versus BCG-Russia to Healthy Newborns in Guinea-Bissau: A Randomized Controlled Trial. Schaltz-Buchholzer F; Bjerregaard-Andersen M; Øland CB; Golding C; Stjernholm EB; Monteiro I; Aaby P; Benn CS Clin Infect Dis; 2020 Nov; 71(8):1883-1893. PubMed ID: 31677386 [TBL] [Abstract][Full Text] [Related]
4. Single versus multi-dose vaccine vials: an economic computational model. Lee BY; Norman BA; Assi TM; Chen SI; Bailey RR; Rajgopal J; Brown ST; Wiringa AE; Burke DS Vaccine; 2010 Jul; 28(32):5292-300. PubMed ID: 20566395 [TBL] [Abstract][Full Text] [Related]
5. The influence of bacille Calmette-Guerin vaccine strain on the immune response against tuberculosis: a randomized trial. Ritz N; Dutta B; Donath S; Casalaz D; Connell TG; Tebruegge M; Robins-Browne R; Hanekom WA; Britton WJ; Curtis N Am J Respir Crit Care Med; 2012 Jan; 185(2):213-22. PubMed ID: 22071384 [TBL] [Abstract][Full Text] [Related]
6. Low birth weight infants and Calmette-Guérin bacillus vaccination at birth: community study from Guinea-Bissau. Roth A; Jensen H; Garly ML; Djana Q; Martins CL; Sodemann M; Rodrigues A; Aaby P Pediatr Infect Dis J; 2004 Jun; 23(6):544-50. PubMed ID: 15194836 [TBL] [Abstract][Full Text] [Related]
7. Disregarding the restrictive vial-opening policy for BCG vaccine in Guinea-Bissau: impact and cost-effectiveness for tuberculosis mortality and all-cause mortality in children aged 0-4 years. Thysen SM; Fisker AB; Byberg S; Aaby P; Roy P; White R; Griffiths U; Harris RC BMJ Glob Health; 2021 Aug; 6(8):. PubMed ID: 34344667 [TBL] [Abstract][Full Text] [Related]
9. Two Randomized Trials of the Effect of the Russian Strain of Bacillus Calmette-Guérin Alone or With Oral Polio Vaccine on Neonatal Mortality in Infants Weighing <2000 g in India. Jayaraman K; Adhisivam B; Nallasivan S; Krishnan RG; Kamalarathnam C; Bharathi M; McSharry B; Namachivayam SP; Shann F; Boopalan SI; David P; Bhat BV Pediatr Infect Dis J; 2019 Feb; 38(2):198-202. PubMed ID: 30256314 [TBL] [Abstract][Full Text] [Related]
10. Bacille Calmette-Guérin: One Hundred Years, One Hundred Questions. Danchuk SN; Behr MA Clin Infect Dis; 2020 Nov; 71(8):1894-1895. PubMed ID: 31677382 [No Abstract] [Full Text] [Related]
11. Implementation of the vaccination program in Guinea-Bissau: Coverage and missed opportunities for BCG at birth. Rasmussen CEH; Vedel JO; Jensen AM; Borges IDS; Furtado O; Meyrowitsch DW; Fisker AB Vaccine; 2024 Oct; 42(23):126056. PubMed ID: 38871573 [TBL] [Abstract][Full Text] [Related]
12. BCG coverage and barriers to BCG vaccination in Guinea-Bissau: an observational study. Thysen SM; Byberg S; Pedersen M; Rodrigues A; Ravn H; Martins C; Benn CS; Aaby P; Fisker AB BMC Public Health; 2014 Oct; 14():1037. PubMed ID: 25282475 [TBL] [Abstract][Full Text] [Related]
13. The effects of switching from 10 to 5-dose vials of MR vaccine on vaccination coverage and wastage: A mixed-method study in Zambia. Krudwig K; Knittel B; Karim A; Kanagat N; Prosser W; Phiri G; Mwansa F; Steinglass R Vaccine; 2020 Aug; 38(37):5905-5913. PubMed ID: 32703746 [TBL] [Abstract][Full Text] [Related]
14. Neonatal Bacille Calmette-Guérin vaccination and tuberculin skin test reactions at 2- and 6-months: Effects on mortality up to 1 year of age. Schaltz-Buchholzer F; Roth A; de Bree LCJ; Biering-Sørensen S; Timmermann CAG; Monteiro I; Aaby P; Benn CS Vaccine; 2021 Dec; 39(50):7286-7294. PubMed ID: 34226104 [TBL] [Abstract][Full Text] [Related]
15. Maternal Bacille Calmette-Guérin Scars and Mortality Risk for Male and Female Newborns: Observational Study From Guinea-Bissau. Schaltz-Buchholzer F; Nielsen S; Sørensen MK; Gomes GM; Hoff S; Toft AM; Stjernholm EB; Monteiro I; Aaby P; Benn CS J Infect Dis; 2024 Oct; 230(4):995-1003. PubMed ID: 38758135 [TBL] [Abstract][Full Text] [Related]
17. BCG skin reactions by 2 months of age are associated with better survival in infancy: a prospective observational study from Guinea-Bissau. Schaltz-Buchholzer F; Berendsen M; Roth A; Jensen KJ; Bjerregaard-Andersen M; Kjær Sørensen M; Monteiro I; Aaby P; Stabell Benn C BMJ Glob Health; 2020 Sep; 5(9):. PubMed ID: 32978212 [TBL] [Abstract][Full Text] [Related]
18. Can BCG vaccination at first health-facility contact reduce early infant mortality? Study protocol for a cluster-randomised trial (CS-BCG). Thysen SM; Møller Jensen A; Vedel JO; da Silva Borges I; Aaby P; Jensen AKG; Benn CS; Fisker AB BMJ Open; 2022 Nov; 12(11):e063872. PubMed ID: 36410811 [TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of providing measles vaccination to all children in Guinea-Bissau. Byberg S; Fisker AB; Thysen SM; Rodrigues A; Enemark U; Aaby P; Benn CS; Griffiths UK Glob Health Action; 2017; 10(1):1329968. PubMed ID: 28580855 [TBL] [Abstract][Full Text] [Related]
20. The budget impact of controlling wastage with smaller vials: A data driven model of session sizes in Bangladesh, India (Uttar Pradesh),Mozambique, and Uganda. Yang W; Parisi M; Lahue BJ; Uddin M; Bishai D Vaccine; 2014 Nov; 32(49):6643-8. PubMed ID: 25306911 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]